Bellwether Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Bellwether Advisors's BMY Position: Q1 2026 in Review
Bellwether Advisors opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 31,105 shares worth $1.89M. The stake represents 0.32% of the portfolio and ranks #71 among its holdings. This is a return to the name: Bellwether Advisors previously reported a position in BMY as recently as Q3 2023.
Bellwether Advisors first reported a position in BMY in Q4 2020 and has held it in 13 quarters since. The position peaked at $2.8M in Q4 2020. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Bellwether Advisors held 31,105 shares of Bristol-Myers Squibb worth $1.89M as of Q1 2026.
- Bristol-Myers Squibb was a new Bellwether Advisors position in Q1 2026.
- Bristol-Myers Squibb made up 0.32% of Bellwether Advisors's portfolio in Q1 2026, its #71 holding.
- Bellwether Advisors first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 13 quarters since.
- Bellwether Advisors's Bristol-Myers Squibb position peaked at $2.8M in Q4 2020.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Bellwether Advisors's 13F filing for Q1 2026, filed 12 May 2026.